TQH3906 not checked

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
4 active
6 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“TQH3906 Capsules is an inhibitor that targets tyrosine kinase 2 (TYK2).”In the company’s words, NCT07724366 on ClinicalTrials.gov
Tested for
Psoriasis, Psoriatic Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Diseases
Main trialPhase 3
“This study is a multicenter, randomized, double-blind, placebo- and active-controlled Phase III clinical trial sponsored by Nanjing Shunxin Pharmaceutical Co., Ltd., a subsidiary of Chiatai Tianqing Pharmaceutical Group. The study aims to evaluate the efficacy and safety of once-daily oral TQH3906 capsules (24 mg) in adult participants with moderate to severe plaque psoriasis. TQH3906 is a highly selective TYK2 allosteric inhibitor targeting the JH2 domain, which blocks the IL-23 and Type I interferon inflammatory pathways. Approximately 400 eligible participants aged 18-75 years will be…”In the company’s words, NCT07724366 on ClinicalTrials.gov

Other drugs for Psoriasis

All 41 drugs for Psoriasis

Coming up4

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Sep 2027 A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
Phase 2Recruiting Aug 2027 A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Phase 2Recruiting Nov 2027 A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
Phase 1Recruiting Jul 2027 Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Phase 2Completed 3 Nov 2025 Treatment of Moderate to Severe Plaque Psoriasis
Phase 1Completed 27 Apr 2025 A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow TQH3906

Following is part of Solo: you see every change to TQH3906 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in